ALNYLAM PHARMACEUTICALS, INC.: capex
| Value | {"amount": 36152000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-03-31 |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c41dbc3d-5c40-4f7b-9bc1-0d75fd56eb2c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-17-008948Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/capex/2017-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c41dbc3d-5c40-4f7b-9bc1-0d75fd56eb2c
History
- no predecessors — first report